In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co, together
with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds
4.92% of the B shares in Novozymes, previously reported at 5.10% in company
announcement no. 51, October 2016.
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford
Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,243,078
shares of a nominal value of DKK 30,486,156, equivalent to 4.92% of Novozymes
A/S’ share capital and 1.92% of the voting rights.